Immortal time bias and infliximab-related mortality and malignancy incidence.
Targownik
Laura Ellyn
LE
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D015982:Bias; D005765:Gastrointestinal Agents / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000401:mortality; D000069285:Infliximab; D009369:Neoplasms / Q000139:chemically induced; D013997:Time Factors
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab